{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:22:15Z","timestamp":1792120935876,"version":"4.4.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer J."],"DOI":"10.1038\/s41408-021-00602-4","type":"journal-article","created":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T15:23:06Z","timestamp":1643296986000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Patient-reported outcome measures are associated with health care utilization in patients with transplant ineligible multiple myeloma: a population-based study"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1584-1067","authenticated-orcid":false,"given":"Hira","family":"Mian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinku","family":"Sutradhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory R.","family":"Pond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Branavan","family":"Sivapathasundaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7702-8816","authenticated-orcid":false,"given":"Jonathan","family":"Sussman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaris","family":"Balitsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1092-5643","authenticated-orcid":false,"given":"Anita","family":"D\u2019Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya M.","family":"Wildes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsien","family":"Seow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,27]]},"reference":[{"key":"602_CR1","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.1002\/cncr.30747","volume":"123","author":"JR Schriber","year":"2017","unstructured":"Schriber JR, Hari PN, Ahn KW, Fei M, Costa LJ, Kharfan-Dabaja MA, et al. Hispanics have the lowest stem cell transplant utilization rate for autologous hematopoietic cell transplantation for multiple myeloma in the United States: a CIBMTR report. Cancer. 2017;123:3141\u20139. https:\/\/doi.org\/10.1002\/cncr.30747.","journal-title":"Cancer"},{"key":"602_CR2","doi-asserted-by":"publisher","first-page":"e152","DOI":"10.1016\/j.clml.2020.09.010","volume":"21","author":"HS Mian","year":"2021","unstructured":"Mian HS, Fiala MA, Wildes TM. Burden of treatment among older adults with newly diagnosed multiple myeloma. Clin Lymphoma Myeloma Leuk. 2021;21:e152\u2013e9. https:\/\/doi.org\/10.1016\/j.clml.2020.09.010.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"602_CR3","doi-asserted-by":"publisher","first-page":"e176","DOI":"10.1200\/JOP.2017.028191","volume":"14","author":"L Panattoni","year":"2018","unstructured":"Panattoni L, Fedorenko C, Greenwood-Hickman MA, Kreizenbeck K, Walker JR, Martins R, et al. Characterizing potentially preventable cancer- and chronic disease-related emergency department use in the year after treatment initiation: a regional study. J Oncol Pract. 2018;14:e176\u2013e85. https:\/\/doi.org\/10.1200\/JOP.2017.028191.","journal-title":"J Oncol Pract"},{"key":"602_CR4","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/1477-7525-8-104","volume":"8","author":"EA Laugsand","year":"2010","unstructured":"Laugsand EA, Sprangers MA, Bjordal K, Skorpen F, Kaasa S, Klepstad P. Health care providers underestimate symptom intensities of cancer patients: a multicenter European study. Health Qual Life Outcomes. 2010;8:104 https:\/\/doi.org\/10.1186\/1477-7525-8-104.","journal-title":"Health Qual Life Outcomes"},{"key":"602_CR5","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1002\/(SICI)1097-0142(20000501)88:9<2164::AID-CNCR24>3.0.CO;2-5","volume":"88","author":"VT Chang","year":"2000","unstructured":"Chang VT, Hwang SS, Feuerman M. Validation of the Edmonton Symptom Assessment Scale. Cancer 2000;88:2164\u201371.","journal-title":"Cancer"},{"key":"602_CR6","doi-asserted-by":"publisher","first-page":"e142","DOI":"10.1200\/JOP.2011.000525","volume":"8","author":"H Seow","year":"2012","unstructured":"Seow H, Sussman J, Martelli-Reid L, Pond G, Bainbridge D. Do high symptom scores trigger clinical actions? An audit after implementing electronic symptom screening. J Oncol Pract. 2012;8:e142\u2013e8. https:\/\/doi.org\/10.1200\/JOP.2011.000525.","journal-title":"J Oncol Pract"},{"key":"602_CR7","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1200\/JCO.20.01845","volume":"39","author":"CW Noel","year":"2021","unstructured":"Noel CW, Sutradhar R, Zhao H, Delibasic V, Forner D, Irish JC, et al. Patient-reported symptom burden as a predictor of emergency department use and unplanned hospitalization in head and neck cancer: a longitudinal population-based study. J Clin Oncol 2021;39:675\u201384. https:\/\/doi.org\/10.1200\/JCO.20.01845.","journal-title":"J Clin Oncol"},{"key":"602_CR8","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.3324\/haematol.2020.267757","volume":"106","author":"HS Mian","year":"2021","unstructured":"Mian HS, Pond GR, Wildes TM, Sivapathasundaram B, Sussman J, Seow H. Symptom burden in transplant ineligible patients with newly diagnosed multiple myeloma: a population-based cohort study. Haematologica 2021;106:1991\u20134. https:\/\/doi.org\/10.3324\/haematol.2020.267757.","journal-title":"Haematologica"},{"key":"602_CR9","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1001\/archinte.160.14.2101.","volume":"160","author":"MR DiMatteo","year":"2000","unstructured":"DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160:2101\u20137. https:\/\/doi.org\/10.1001\/archinte.160.14.2101.","journal-title":"Arch Intern Med"},{"key":"602_CR10","doi-asserted-by":"publisher","first-page":"e1098","DOI":"10.1634\/theoncologist.2019-0709","volume":"25","author":"J Hallet","year":"2020","unstructured":"Hallet J, Davis LE, Isenberg-Grzeda E, Mahar AL, Zhao H, Zuk V, et al. Gaps in the management of depression symptoms following cancer diagnosis: a population-based analysis of prospective patient-reported outcomes. Oncologist 2020;25:e1098\u2013e108. https:\/\/doi.org\/10.1634\/theoncologist.2019-0709.","journal-title":"Oncologist"},{"key":"602_CR11","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1200\/JCO.2013.53.5948","volume":"32","author":"G Kotronoulas","year":"2014","unstructured":"Kotronoulas G, Kearney N, Maguire R, Harrow A, Di Domenico D, Croy S, et al. What is the value of the routine use of patient-reported outcome measures toward improvement of patient outcomes, processes of care, and health service outcomes in cancer care? A systematic review of controlled trials. J Clin Oncol 2014;32:1480\u2013501. https:\/\/doi.org\/10.1200\/JCO.2013.53.5948.","journal-title":"J Clin Oncol"},{"key":"602_CR12","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1001\/jama.2017.7156","volume":"318","author":"E Basch","year":"2017","unstructured":"Basch E, Deal AM, Dueck AC, Scher HI, Kris MG, Hudis C, et al. Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. J Am Med Assoc. 2017;318:197\u20138. https:\/\/doi.org\/10.1001\/jama.2017.7156.","journal-title":"J Am Med Assoc"},{"key":"602_CR13","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.annemergmed.2012.10.010","volume":"61","author":"L Barbera","year":"2013","unstructured":"Barbera L, Atzema C, Sutradhar R, Seow H, Howell D, Husain A, et al. Do patient-reported symptoms predict emergency department visits in cancer patients? A population-based analysis. Ann Emerg Med 2013;61:427\u201337. https:\/\/doi.org\/10.1016\/j.annemergmed.2012.10.010.","journal-title":"Ann Emerg Med"},{"key":"602_CR14","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.jpainsymman.2019.07.007","volume":"58","author":"R Sutradhar","year":"2019","unstructured":"Sutradhar R, Rostami M, Barbera L. Patient-reported symptoms improve performance of risk prediction models for emergency department visits among patients with cancer: a population-wide Study in Ontario Using Administrative Data. J Pain Symptom Manag 2019;58:745\u201355. https:\/\/doi.org\/10.1016\/j.jpainsymman.2019.07.007.","journal-title":"J Pain Symptom Manag"},{"key":"602_CR15","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1634\/theoncologist.2017-0592","volume":"23","author":"N Duma","year":"2018","unstructured":"Duma N, Azam T, Riaz IB, Gonzalez-Velez M, Ailawadhi S, Go R. Representation of minorities and elderly patients in multiple myeloma clinical trials. Oncologist 2018;23:1076\u20138. https:\/\/doi.org\/10.1634\/theoncologist.2017-0592.","journal-title":"Oncologist"},{"key":"602_CR16","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1016\/j.clml.2018.08.019","volume":"19","author":"N Despi\u00e9gel","year":"2019","unstructured":"Despi\u00e9gel N, Touboul C, Flinois A, Saba G, Suzan F, Gonzalez-McQuire S, et al. Health-related quality of life of patients with multiple myeloma treated in routine Clinical Practice in France. Clin Lymphoma Myeloma Leuk. 2019;19:e13\u2013e28. https:\/\/doi.org\/10.1016\/j.clml.2018.08.019.","journal-title":"Clin Lymphoma Myeloma Leuk"}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41408-021-00602-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-021-00602-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-021-00602-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T20:02:16Z","timestamp":1669233736000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41408-021-00602-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,27]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1]]}},"alternative-id":["602"],"URL":"https:\/\/doi.org\/10.1038\/s41408-021-00602-4","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,27]]},"assertion":[{"value":"12 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"HM: Consultancy\/Honoraria fees from Celgene, Takeda, Janssen, Amgen, Sanofi, Research funding Janssen. RS: None. GP: Current hold of individual stocks of Roche Canada. Consultancy fees from Astra-Zeneca, Merck and Profound Medical. Membership on Advisory committee for Takeda. TW: Consultancy fees from Janssen, Carevive, Seattle Genetics, Sanofi. AD: Institutional Research Funding from Sanofi, Takeda, TeneoBio, Caelum, Prothena, Consultancy\/Advisory Board fees- Janssen, Prothena, Imbrium, Pfizer, BMS. AB: None. BS: None. JS: None. HS: None.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17"}}